1. Home
  2. OCGN vs WILC Comparison

OCGN vs WILC Comparison

Compare OCGN & WILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • WILC
  • Stock Information
  • Founded
  • OCGN 2013
  • WILC 1994
  • Country
  • OCGN United States
  • WILC Israel
  • Employees
  • OCGN N/A
  • WILC N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • WILC Food Distributors
  • Sector
  • OCGN Health Care
  • WILC Consumer Discretionary
  • Exchange
  • OCGN Nasdaq
  • WILC Nasdaq
  • Market Cap
  • OCGN 189.6M
  • WILC 201.1M
  • IPO Year
  • OCGN N/A
  • WILC 1997
  • Fundamental
  • Price
  • OCGN $0.68
  • WILC $14.93
  • Analyst Decision
  • OCGN Strong Buy
  • WILC
  • Analyst Count
  • OCGN 3
  • WILC 0
  • Target Price
  • OCGN $6.33
  • WILC N/A
  • AVG Volume (30 Days)
  • OCGN 4.3M
  • WILC 15.8K
  • Earning Date
  • OCGN 05-13-2025
  • WILC 05-19-2025
  • Dividend Yield
  • OCGN N/A
  • WILC 3.90%
  • EPS Growth
  • OCGN N/A
  • WILC 122.00
  • EPS
  • OCGN N/A
  • WILC 1.39
  • Revenue
  • OCGN $4,054,999.00
  • WILC $158,085,550.00
  • Revenue This Year
  • OCGN N/A
  • WILC N/A
  • Revenue Next Year
  • OCGN N/A
  • WILC N/A
  • P/E Ratio
  • OCGN N/A
  • WILC $10.73
  • Revenue Growth
  • OCGN N/A
  • WILC 5.99
  • 52 Week Low
  • OCGN $0.52
  • WILC $8.18
  • 52 Week High
  • OCGN $2.06
  • WILC $17.58
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 51.84
  • WILC 45.82
  • Support Level
  • OCGN $0.64
  • WILC $13.40
  • Resistance Level
  • OCGN $0.74
  • WILC $15.30
  • Average True Range (ATR)
  • OCGN 0.07
  • WILC 1.06
  • MACD
  • OCGN 0.00
  • WILC 0.06
  • Stochastic Oscillator
  • OCGN 54.50
  • WILC 79.67

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About WILC G. Willi-Food International Ltd.

G. Willi-Food International Ltd is a company engaged in high-quality, great-tasting kosher food products. The Company is engaged, directly and through subsidiaries, with one segment Import-export, marketing, and distribution of food products. The principal product line includes Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Dried Fruit, Nuts and Beans, and Other Products. Its brands include Willi-Food, Euro European Dairies, Donna Rozza, Manchow, Gold Frost, Tifeeret, The Chef Dish, Art Coffe, Mr. Chang, Muchi, Euro Butter, Euro Spread, Euro Cheese, Euro Cream, Euro Dessert, Euro Veg, Ha-Bulgaria, Gelato, and Emma.

Share on Social Networks: